Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. [electronic resource]
- Critical care medicine Jul 2006
- 1883-91 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0090-3493
10.1097/01.CCM.0000220764.10155.03 doi
6-Ketoprostaglandin F1 alpha--biosynthesis Animals Anticoagulants--pharmacology Calcium--blood Cyclooxygenase 2 Inhibitors--pharmacology Dalteparin--pharmacology Edema--diagnosis Endothelium--metabolism Epoprostenol--biosynthesis Fibrin Fibrinogen Degradation Products--analysis Heparin--pharmacology In Vitro Techniques Indomethacin--pharmacology Inflammation--drug therapy Interleukin-12--blood Leukocytes--physiology Liver--blood supply Liver Diseases--prevention & control Male Monocytes--chemistry Naphthalenes--pharmacology Nitrobenzenes--pharmacology Peroxidase--analysis Propionates--pharmacology Prospective Studies Random Allocation Rats Rats, Wistar Reperfusion Injury--prevention & control Sulfonamides--pharmacology Transaminases--blood Tumor Necrosis Factor-alpha--analysis